Innova Captab Ltd Q3 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/yznafvoqnmdyn5t5j5ehdbgt.pdf

Key Takeaways


Jammu Facility: The Growth Engine

Lohariwala: "We have already developed almost 30-plus products in our R&D and that will be rolled to the production floor. We have started doing the process validation and generation of the data."

Sharon: The Deferred Quarter


CDMO & Domestic Generic: The Steady Base

Lohariwala: "So there the growth comes not only from the IPM growth but from the product shift also. The product shift may be from site to site or from in-house to site."

Margins: Gradual Improvement Path


International Expansion & Regulatory Positioning

Lohariwala: "Our facility is well compliant and we have our own sense rather than speculating on the government implementation of the Schedule M and all that. We have our own strength."

Guidance & Commitments

CommitmentSpecificsTimeline
Jammu facility revenue₹400–500 crores incremental revenue (₹450–550 crores total including transfers)FY26
Jammu Q4 FY25 revenue₹20–40 croresQ4 FY25
Jammu path to scaleReach ₹1,000 crores2–3 years
Jammu capacity utilization30–35% initial year; 50–55% by year 2–3; ~10% growth thereafterFY26–FY30
Jammu stabilized marginIn line with base business at 15–16% EBITDAOnce at ₹400–500 crores run-rate
Jammu annual depreciation₹20–25 crores per annumOngoing from commercialization
Sharon growthEarly teens growthComing years
Sharon marginStable at current levelsComing years
Overall growth next year25%+ (confirmed "Yes, of course")FY26
Long-term margin improvement100–200 bps possible; clearer picture after one yearFY27/FY28

Key Metrics

MetricQ3 FY25
Consolidated revenue₹316.5 cr, +5% YoY
CDMO revenue₹172.2 cr, 54% of topline
Domestic generic revenue₹58.6 cr, 19% of topline
International generic revenue₹41.2 cr, +17% YoY, 13% of topline
Sharon revenue₹44.5 cr, -6.5% YoY, 14% of topline
EBITDA₹50.9 cr, margin 16.1%, +60 bps YoY
Profit after tax₹34.2 cr, +36.3% YoY
PAT margin10.8%, vs 8.3% in Q3 FY24
9M FY25 consolidated revenue₹928.9 cr, +13.5% YoY
9M FY25 CDMO revenue₹505.1 cr
9M FY25 domestic generic revenue₹169 cr, +18% YoY
9M FY25 international generic revenue₹113 cr
9M FY25 Sharon revenue₹141.9 cr
CDMO volume growth (9M YoY)early teens
Jammu facility Q4 FY25 revenue estimate₹20 cr to ₹40 cr
Jammu facility FY26 revenue target₹400 cr to ₹500 cr incremental
Jammu facility peak utilization70% to 75%, revenue potential of ₹1,500 cr to ₹1,600 cr
Jammu facility annual depreciation estimate₹20 cr to ₹25 cr
Jammu facility current headcount500 to 600 plus apprentices
Jammu facility peak headcount1,200 to 1,300
Distribution touch points1,50,000
Domestic product portfolio600 products
Export countries25
Manufacturing facilities5 facilities, 9 independent production blocks
GST-linked incentive on Jammu investment300% of eligible plant and machinery investment, available up to 10 years
Interest cost reduction on Jammu loans~600 bps via capital interest subvention
Sharon deferred orders (Q3 to Q4)₹4 cr to ₹5 cr
Blended consolidated EBITDA margin range15.5% to 16%